Denmark· DK-28103199000
Cancidas
A caspofungin product containing caspofunginacetat, registered in Denmark by Merck Sharp & Dohme B.V.. The same ATC class is registered in 18 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Caspofungin is registered in 18 of 19 countries.
Countries holding a registration under ATC J02AX04 (caspofungin), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 10 of them publish a price we can compare per daily dose
Caspofungin · ATC J02AX04
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of caspofungin costs, country by country.
Normalised to the WHO defined daily dose (50 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Caspofungin · price per daily dose (50 mg)
USD · FX 28 Sept 2026
- CH Switzerland$358.98
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- CASPOFUNGINACETAT
- Manufacturer
- Merck Sharp & Dohme B.V.
- Country
- Denmark (DK)
- ATC code
- J02AX04
- ATC class
- Caspofungin
- Defined daily dose
- 50 mg, P
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28103199000
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
112 interactions on record for caspofungin.
Graded by severity as the source publishes them — 6 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Caspofungin · interactions on record
112 records
- 6 severe
- 35 moderate
- 71 info
Most severe, free to view
- DexamethasoneH02AB02severe
- LeflunomidL04AA13severe
- TeriflunomidL04AA31severe
- LeflunomideL04AK01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under J02AX04
Caspofungin, as other registers publish it.
- PolandCancidasMerck Sharp & Dohme B.V.
- IcelandCancidasMerck Sharp & Dohme B.V.*
- PolandCancidasMerck Sharp & Dohme B.V.
- FinlandCancidasMerck Sharp & Dohme B.V.
- DenmarkCancidasMerck Sharp & Dohme B.V.
- IcelandCancidasMerck Sharp & Dohme B.V.*
- FinlandCancidasMerck Sharp & Dohme B.V.
- NorwayCancidasMerck Sharp & Dohme B.V. (1)
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/db8e2794-bb70-499f-9930-367cdcdfea85 GET /v1/drugs/db8e2794-bb70-499f-9930-367cdcdfea85?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "pulver til koncentrat til infusionsvæske, opløsning",
"source": "dkma",
"strength": "70 mg",
"auth_role": "MOD",
"dk_drugid": "28103199000",
"substance": "CASPOFUNGINACETAT",
"auth_procedure": "Central",
"in_medicinpriser": false,
"registration_date_serial": "37188"
}See everything about caspofungin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.